💊370: Diabetes Pharmacology Flashcards Preview

Nursing - Bloomberg > 💊370: Diabetes Pharmacology > Flashcards

Flashcards in 💊370: Diabetes Pharmacology Deck (89)
Loading flashcards...
1
Q

What are the metabolic defects of Diabetes Mellitus?

A
  1. Insulin deficiency
    And/Or
  2. Defective insulin action (insulin resistance)
2
Q

What is insulin?

A

Protein with 2 linked amino acid chains.

Synthesized in the pancreas by Beta cells in islets of Langerhans.

3
Q

Where is insulin synthesized?

A

pancreas by Beta cells in islets of Langerhans.

4
Q

What are triggers for insulin secretion?

A
  1. Blood glucose

2. Amino acids, fatty acids

5
Q

What are normal blood glucose levels?

A

4.0 - 7.7 mmol/L

6
Q

What are dangerous hypoglycaemic levels?

A

Brain requires > 2.5 mmol/L

Seizures and coma at < 2.0 mmol/L

7
Q

What are the levels of hyperglycaemia and what occurs?

A

Glucose in urine > 10 mmol/L

  • Osmotic diuresis, dehydration, thirst

Type 1: Diabetic ketoacidosis (DKA)
Type 2: hyperglycaemic Hyperosmolar State (HHS)

8
Q

What are abnormal results for FPG test?

A

No caloric intake for at least 8 hours

IFG: 6.1 - 6.9
Diabetes >= 7.0

9
Q

What are abnormal results for the 2hPG in a 75g OGTT test?

A

IFG: 7.8 - 11.0
Diabetes: >= 11.1

10
Q

What are abnormal results for the A1C test?

A

Prediabetes: 6.0 - 6.4

Diabetes >= 6.5

11
Q

What are abnormal results for the Random PG test?

A

Diabetes >= 11.1

12
Q

What is the mechanism of normal Prandial Glucose metabolism?

A
  1. ⬆️ BG stimulates pancreatic insulin release
  2. Insulin allows glucose uptake by muscle and fat
  3. Insulin inhibits glucose production by liver
  4. Insulin’s inhibits breakdown of TG to fatty acids and proteins to amino acids

Result: BG < 7.8 mmol/L

13
Q

What is the normal mechanism of Fasting glucose metabolism?

A
  1. Low insulin secretion, little glucose uptake by peripheral tissues
  2. Counter-regulating hormones (CRH) stimulate glucose production in liver
  3. Hepatic glucose production:
    A) Glycogenolysis
    B) Gluconeogenesis

Result: BG > 4.0 mmol/L

14
Q

What is Glucogenolysis?

A

Breakdown of glycogen into glucose in the liver

15
Q

What is Gluconeogenesis?

A

Synthesis of glucose from breakdown of proteins or TG in the liver

16
Q

What are macro vascular complications with DM?

A
  1. Stroke
  2. CAD, Hypertension
  3. Peripheral Vascular Disease
  4. Diabetes Foot
17
Q

What are microvascular complications of DM?

A
  1. Retinopathy and Cataracts
  2. Nephropathy
  3. Neuropathy
  4. Diabetic Foot
18
Q

What are therapeutic goals for patients with diabetes?

A
  1. Normalize blood sugars
  2. Percent/resolve symptoms
  3. Prevent acute and chronic complications
  4. Avoid negative sequels if therapy (ie. hypoglycaemia)
19
Q

What are the ABCDES for all patients with diabetes?

A
A = A1C  =<7%
B = BP <130/80
C = Cholesterol LDL-C =< 2.0 mmol/L
D = Drugs to protect the heart 
E = Exercise / Eating 
S = Smoking cessation
20
Q

What are therapeutic interventions for glycemic control?

A
  1. Diet
  2. Exercise
  3. Oral hypoglycaemic agents
  4. Insulin
21
Q

Why is exercise important for diabetic patients?

A
  1. Exercise ⬆️ insulin sensitivity and glucose tolerance

2. Promotes weight loss

22
Q

What are the glycemic target lab values?

A

A1C =< 7.0%
Preprandial PG: 4.0 - 7.0 mmol/L
2hPG: 5.0 -10.0 mmol/L (5-8 if not at target)

23
Q

What drugs cause Hyperglycaemia?

A
  1. Corticosteroids
  2. Diuretics (ex. Thiazides)
  3. Protease inhibitors
  4. Sympathomimetics (ex. Epinephrine)
  5. Clycosporine, tacrolimus
  6. Phenytoin
  7. Sudafed??

⬇️ insulin secretion, ⬆️ insulin resistance, or ⬆️ hepatic glucose output

24
Q

What drugs cause hypoglycaemia?

A
  1. Alcohol (hepatic output)
  2. Beta blockers (hepatic output)
    (Can mask hypoglycaemia symptoms such as tachycardia, tremors)
25
Q

What are prototypes of Short Acting (“Regular”) insulin’s?

A

Humulin R

Novolin ge Toronto

26
Q

What are Short Acting (“Regular”) insulins?

A

Unmodified human insulin

  • Used to control prandial glucose
  • SC, IM, IV

DOSE 30-60 min before meals

27
Q

What are prototypes of Rapid Acting Insulin Analogs?

A

Slightly modified human insulin

  • Very fast onset and short duration
  • Control prandial glucose
  • SC or IV

DOSE immediately before/during meals

28
Q

What are prototypes of Rapid Acting Insulin Analogs?

A

Lispro (Humalog)
Aspart (NovoRapid)
Glulisine (Apidra)

29
Q

What are Intermediate Acting Insulin?

A

Neutral Protamine Hagedorn (NPH)

  • Insulin conjugated with protamine to ⬇️ solubility and slow absorption
  • Delayed inset, extended duration
  • SUSPENSION for SC (never IV!!!)

DOSE twice a day

30
Q

What are common prototypes of Intermediate Acting Insulin?

A

Humulin N

Novolin ge NPH

31
Q

What are Long Acting Insulin Analogs?

A

Modified human insulin
Low solubility at physiologic pH
Act as DEPOT when injected SC (slowly release over 24hrs)
Lacks peak effect => ideal Nadal insulin

32
Q

What are prototypes of Long Acting Insulin Analogs?

A
  1. Glargine (Lantus, Basaglar)

2. Detener (Levemir)

33
Q

What are advantages of Long Acting Insulin?

A
  1. No peak activity, consistent insulin levels
  2. Less risk of hypoglycaemia (esp nocturnal)
  3. Longer duration of action allows for daily dosing
34
Q

What are Ultra Long Acting Insulin Analogs?

A

Modified human insulin with duration of action of 42 hours

Can give missed dose as late as 16 hours after

35
Q

What is a prototype of Ultra Long Acting Insulin?

A

Degludec (Tresiba)

36
Q

What are two prototypes of Pre-Mixed Insulin’s?

A
  1. Humulin 30/70 (30% regular, 70% NOH)

2. Humalog Mix25 (25% lispro, 75% NPL)

37
Q

What some advantages and disadvantages of Pre-Mixed insulin’s?

A

Advantage:
Convenient, less chance for error or cross-contamination

Disadvantage:
No flexibility to change doses, so cannot achieve optimal BG control

38
Q

What are side effects of insulin?

A
  1. HYPOGLYCAEMIA
  2. Weight gain
  3. Hypokalemia
  4. Local allergic rxns (rare)
  5. Injection site rxns (rotate sites)
39
Q

What are symptoms of Hypoglycemia?

A
  1. BG < 4.0 mmol/L
  2. Tremor, weakness
  3. Palpitations
  4. Tachycardia
  5. Sweating
  6. Tingling lips
  7. Hunger
  8. Blurred vision
  9. Agitation
  10. Restless sleep, nightmares
  11. Morning HA “hangover”
40
Q

What are risk factors for Hypoglycemia?

A
  1. Elderly (⬇️ CRH response)
  2. Renal/hepatic dysfunction
  3. Intensive insulin therapy
  4. Drugs (SFU, alcohol)
  5. Beta-Blockers can mask symptoms **
41
Q

What is the usual management of Hypoglycemia?

A

15-20g CHO orally

42
Q

What is the general onset, peak, and duration of Rapid-Acting insulin analogues?

A

Onset: 10-15 min
Peak: 1 - 2 hours
Duration: 3-5 hours

43
Q

What is the general onset, peak, and duration of Short-Acting insulins?

A

Onset: 30 min
Peak: 2 -3 hours
Duration: 6.5 hours

44
Q

What is the general onset, peak, and duration of Intermediate-Acting insulins?

A

Onset: 1-3 hours
Peak: 5-8 hours
Duration: Up to 18 hours

45
Q

What is the general onset, peak, and duration of Long-Acting insulin analogues?

A

Onset: 90 min
Peak: N/A
Duration: Up to 24 hours

46
Q

What are components of a Basal-Bolus insulin regimen?

A
  1. BASAL insulin = (usually long-Acting) controls BG between meals
  2. BOLUS insulin = (usually rapid-acting) controls prandial BG
  3. Insulin correction = additional PRN rapid-Acting
  4. Titrate = BG monitoring at least 4 times daily with dose adjustments
47
Q

What are components of Conventional insulin regimen?

A
  1. Rapid or Short-Acting
  2. Intermediate-Acting Insulin

Both take in Morning and Evening

48
Q

What are advantages of Basal-Bolus insulin regimens?

A
  1. Better prandial and fasting BG control
  2. More flexibility with meals and timing
  3. ⬇️ in micro vascular complications
  4. ⬇️ macro vascular complications
  5. Best for Type 1 patients
49
Q

What are disadvantages of Basal-Bolus insulin regimens?

A
  1. ⬆️ risk of hypoglycemia
  2. Weight gain
  3. ⬆️ injections and BG monitoring
  4. Patient must be motivated and educated
50
Q

What is a Sliding Scale?

A

Regular or rapid-Acting insulin given in response to regular BG measurements

  1. Reactive approach
  2. Short-term use only
  3. Not proactive
51
Q

How do colds/illness impact diabetic patients?

A

Stress ➡️ release CRH ➡️ Hyperglycemia

52
Q

How does exercise impact diabetes?

A

Exercise (esp aerobic) ⬆️ insulin sensitivity during and after ➡️ Risk of Hypoglycaemia (esp Type 1)

53
Q

How do insulin pumps work?

A
  1. “Reservoir”
  2. “Cannula”
  3. “Infusion set” holds needle in place
  4. Rapid-Acting Insulin only
54
Q

What are advantages of insulin pumps?

A
  1. More consistent and better BG control
  2. Fewer episodes of Hypoglycaemia
  3. Flexibility (adjust rate PRN)
  4. No injections
55
Q

What are disadvantages of insulin pumps?

A
  1. Risk of Sever hyperglycaemia/DKA if pump fails
  2. Cost (pump+supplies)
  3. Education and training
56
Q

What is the site of action for Metformin?

A

⬇️ hepatic glucose production
⬆️ insulin action

Lowers fasting (FPG) and post-prandial glucose (PPG)

57
Q

What are advantages of Metformin?

A
  1. No Hypoglycaemia (does not stimulate insulin release)
  2. No weight gain
  3. ⬇️ risk diabetic complications
58
Q

What are side effects of Metformin?

A
  1. GI intolerance
  2. Lactic acidosis (rare but potentially fatal)
  3. Accumulation in kidneys ➡️ renal dysfunction (avoid if GFR <30)
  4. Dosed 2-3 times daily with meals
59
Q

What are Thiazolidinediones?

A

⬇️ hepatic glucose production
⬆️ insulin action

Lowers FPG and PPG

60
Q

What is a prototype of Thiazolidinediones?

A

Pioglitazone (Actos)

“-glitazone”

61
Q

What are side effects of Glitazones?

A
  1. No Hypoglycaemia
  2. Heart failure due to fluid retention (avoid in CHF)
  3. ⬆️ risk MI
  4. Hepatotoxicity (monitor LFTs)
  5. CYP450 levels
62
Q

What is the dosing and administration of of Glitazones?

A

Once to twice daily without regard to meals

63
Q

What is the site of action for Sulfonylureas?

A

⬇️ pancreatic insulin secretion

Lower FPG and PPG

64
Q

What is a prototype of Sulfonylureas?

A

Glyburide (Diabeta)

65
Q

What are side effects of Sulfonylureas?

A
  1. Hypoglycaemia (take with meals)
  2. Weight gain
  3. Sulfa allergy
  4. Accumulation + renal dysfunction (⬆️risk hypoglycaemia)
66
Q

What is the site/mechanism of action for Meglitinides?

A

⬆️ pancreatic insulin secretion
Metabolized and secreted by liver in bile (short half-life, 1 hour)

Mainly lower PPG, minimal effect on FPG
Rapid onset

67
Q

What are side effects of Meglitinides?

A
  1. Hypoglycaemia
  2. Weight gain
  3. Liver dysfunction ➡️ accumulation ➡️ hypoglycaemia
68
Q

What are incretin hormones?

A
  1. Released in gut due to ⬆️ BG
  2. Stimulate pancreatic insulin secretion
  3. Inhibit release of glucagon
  4. ⬇️ hepatic glucose production
  5. Rapidly inactivated in body by enzyme DPP-4
69
Q

What are DPP-4 inhibitors?

A

⬆️ levels and prolong activity of incretin hormones

Lower PPG, minimal effect on FPG

70
Q

What is a prototype of DDP-4 inhibitors?

A

Sitagliptin (Januvia)

“-gliptin”

71
Q

What are side effects of DDP-4 inhibitors?

A
  1. HA
  2. Infection (resp, UTI)
  3. Pancreatitis risk
  4. Gallstones
  5. High Triglycerides
  6. Renal dysfunction
72
Q

What is the mechanism of action of Glucagon-Like Peptide-1 Agonists (GLP-1 Agonists)?

A
  1. Stimulate pancreatic GLP-1 receptors
  2. ⬆️ incretin activity
  3. Glucose-dependent effects (insulin secretion stimulated, glucagon release suppressed)
  4. Delays gastric emptying, suppressed appetite
  5. Lower PPG, minimal effect on FPG
73
Q

What are side effects of GLP-1 Agonists?

A
  1. Weight loss (NO Hypoglycaemia)
  2. GI side effects (n/v, diarrhea)
  3. Pancreatitis
  4. Renal dysfunction

SC injection 1-2/day

74
Q

What is the site/mechanism of action for Sodium-Glucosr Co-Transporter 2 (SGLT-2) inhibitors ?

A
  1. Glucose reabsorption in kidney tubules occurs via SGLT-2 co-transporter
  2. Blockade causes glucosuria
  3. Improved glycemic control and weight loss

Lower FPG and PPG

75
Q

What are side effects and interactions for SGLT-2 inhibitors?

A
  1. ⬆️ urination,
  2. Genital yeast infection
  3. UTI
  4. Postural hypotension, dizziness
  5. Diuretics (dehydration, volume depletion)
  6. ⬇️ efficacy with rifampin, phenobarbital, and phenytoin
76
Q

What is a prototype of SGLT-2 inhibitors?

A

Canagliflozin (Invokana)

“-gliflozin”

77
Q

What is the mechanism of action for Acarbose (Glucobay)?

A

Inhibit gut enzyme alpha-glucosidase which breaks down carbohydrates (CHO)

Lowers PPG, no effect on FPG

78
Q

What are side effects of Acarbose (Glucobay)?

A

No systemic side effects

  1. GI side effects (bloating, gas, diarrhea)
79
Q

What are benefits of Acarbose (Glucobay)?

A

Minimal systemic absorption

80
Q

What are drug interactions with Acarbose (Glucobay)?

A

Decreases Metformin absorption

+ ⬆️ GI side effects

81
Q

How do you convert mg/L to mmol/L?

A

Divide by 18

82
Q

What Non-Insulin agents decrease glucose production in the liver?

A
  1. Metformin
  2. Glitazones
  3. DPP-4 inhibitors
  4. GLP-1 agonists
83
Q

Which non-insulin agents increase pancreatic insulin secretion?

A
  1. Sulfonylureas
  2. Meglitinides
  3. DPP-4 inhibitors
  4. GLP-1 agonists
84
Q

Which non-insulin agents decrease pancreatic glucagon secretion?

A
  1. DPP-4 inhibitors

2. GLP-1 agonists

85
Q

Which non-insulin agents increase insulin action/glucose uptake in muscles and fat?

A
  1. Glitazones

2. Metformin

86
Q

Which non-insulin agents increase glucose secretion in the kidneys?

A

SGLT2 inhibitors

87
Q

Which non-insulin agents decrease glucose absorption in the intestines?

A
  1. Acarbose
  2. Orlistat
  3. DPP-4 inhibitors
88
Q

Which drugs have potential cause weight gain?

A
  1. Insulins
  2. Sulfonylureas
  3. Meglitinides
  4. Thiazolidinediones
89
Q

Which drugs may cause Hypoglycaemia?

A
  1. Insulin’s
  2. Sulfonylureas
  3. Meglitinides